OBJECTIVE: Raman spectroscopy has been employed to discriminate between malignant (basal cell carcinoma [BCC] and melanoma [MEL]) and normal (N) skin tissues in vitro, aimed at developing a method for cancer diagnosis. BACKGROUND DATA: Raman spectroscopy is an analytical tool that could be used to diagnose skin cancer rapidly and noninvasively. METHODS: Skin biopsy fragments of ≈ 2 mm(2) from excisional surgeries were scanned through a Raman spectrometer (830 nm excitation wavelength, 50 to 200 mW of power, and 20 sec exposure time) coupled to a fiber optic Raman probe. Principal component analysis (PCA) and Euclidean distance were employed to develop a discrimination model to classify samples according to histopathology. In this model, we used a set of 145 spectra from N (30 spectra), BCC (96 spectra), and MEL (19 spectra) skin tissues. RESULTS: We demonstrated that principal components (PCs) 1 to 4 accounted for 95.4% of all spectral variation. These PCs have been spectrally correlated to the biochemicals present in tissues, such as proteins, lipids, and melanin. The scores of PC2 and PC3 revealed statistically significant differences among N, BCC, and MEL (ANOVA, p<0.05) and were used in the discrimination model. A total of 28 out of 30 spectra were correctly diagnosed as N, 93 out of 96 as BCC, and 13 out of 19 as MEL, with an overall accuracy of 92.4%. CONCLUSIONS: This discrimination model based on PCA and Euclidean distance could differentiate N from malignant (BCC and MEL) with high sensitivity and specificity.
OBJECTIVE: Raman spectroscopy has been employed to discriminate between malignant (basal cell carcinoma [BCC] and melanoma [MEL]) and normal (N) skin tissues in vitro, aimed at developing a method for cancer diagnosis. BACKGROUND DATA: Raman spectroscopy is an analytical tool that could be used to diagnose skin cancer rapidly and noninvasively. METHODS: Skin biopsy fragments of ≈ 2 mm(2) from excisional surgeries were scanned through a Raman spectrometer (830 nm excitation wavelength, 50 to 200 mW of power, and 20 sec exposure time) coupled to a fiber optic Raman probe. Principal component analysis (PCA) and Euclidean distance were employed to develop a discrimination model to classify samples according to histopathology. In this model, we used a set of 145 spectra from N (30 spectra), BCC (96 spectra), and MEL (19 spectra) skin tissues. RESULTS: We demonstrated that principal components (PCs) 1 to 4 accounted for 95.4% of all spectral variation. These PCs have been spectrally correlated to the biochemicals present in tissues, such as proteins, lipids, and melanin. The scores of PC2 and PC3 revealed statistically significant differences among N, BCC, and MEL (ANOVA, p<0.05) and were used in the discrimination model. A total of 28 out of 30 spectra were correctly diagnosed as N, 93 out of 96 as BCC, and 13 out of 19 as MEL, with an overall accuracy of 92.4%. CONCLUSIONS: This discrimination model based on PCA and Euclidean distance could differentiate N from malignant (BCC and MEL) with high sensitivity and specificity.
Authors: Annieke Nijssen; Kees Maquelin; Luis F Santos; Peter J Caspers; Tom C Bakker Schut; Jan C den Hollander; Martino H A Neumann; Gerwin J Puppels Journal: J Biomed Opt Date: 2007 May-Jun Impact factor: 3.170
Authors: Chad A Lieber; Shovan K Majumder; Dean Billheimer; Darrel L Ellis; Anita Mahadevan-Jansen Journal: J Biomed Opt Date: 2008 Mar-Apr Impact factor: 3.170
Authors: F M Lyng; E O Faoláin; J Conroy; A D Meade; P Knief; B Duffy; M B Hunter; J M Byrne; P Kelehan; H J Byrne Journal: Exp Mol Pathol Date: 2007-01-12 Impact factor: 3.362
Authors: Jason T Motz; Maryann Fitzmaurice; Arnold Miller; Saumil J Gandhi; Abigail S Haka; Luis H Galindo; Ramachandra R Dasari; John R Kramer; Michael S Feld Journal: J Biomed Opt Date: 2006 Mar-Apr Impact factor: 3.170
Authors: Abigail S Haka; Zoya Volynskaya; Joseph A Gardecki; Jon Nazemi; Joanne Lyons; David Hicks; Maryann Fitzmaurice; Ramachandra R Dasari; Joseph P Crowe; Michael S Feld Journal: Cancer Res Date: 2006-03-15 Impact factor: 12.701
Authors: Maria C Uzquiano; Victor G Prieto; Jason W Nash; Doina S Ivan; Yun Gong; Alexander J F Lazar; A Hafeez Diwan Journal: Mod Pathol Date: 2008-01-25 Impact factor: 7.842
Authors: Rachel E Kast; Gulay K Serhatkulu; Alex Cao; Abhilash K Pandya; Houbei Dai; Jagdish S Thakur; Vaman M Naik; Ratna Naik; Michael D Klein; Gregory W Auner; Raja Rabah Journal: Biopolymers Date: 2008-03 Impact factor: 2.505
Authors: Chad A Lieber; Shovan K Majumder; Darrel L Ellis; D Dean Billheimer; Anita Mahadevan-Jansen Journal: Lasers Surg Med Date: 2008-09 Impact factor: 4.025
Authors: Nicholas Stone; Maria Consuelo Hart Prieto; Paul Crow; Jeremy Uff; Alistair William Ritchie Journal: Anal Bioanal Chem Date: 2006-11-23 Impact factor: 4.142
Authors: Xu Feng; Austin J Moy; Hieu T M Nguyen; Jason Zhang; Matthew C Fox; Katherine R Sebastian; Jason S Reichenberg; Mia K Markey; James W Tunnell Journal: Biomed Opt Express Date: 2017-05-04 Impact factor: 3.732
Authors: Samantha L Schneider; Indermeet Kohli; Iltefat H Hamzavi; M Laurin Council; Anthony M Rossi; David M Ozog Journal: J Am Acad Dermatol Date: 2018-12-04 Impact factor: 11.527
Authors: Samantha L Schneider; Indermeet Kohli; Iltefat H Hamzavi; M Laurin Council; Anthony M Rossi; David M Ozog Journal: J Am Acad Dermatol Date: 2018-12-04 Impact factor: 11.527
Authors: Yao Zhang; Austin J Moy; Xu Feng; Hieu T M Nguyen; Katherine R Sebastian; Jason S Reichenberg; Claus O Wilke; Mia K Markey; James W Tunnell Journal: Molecules Date: 2020-06-20 Impact factor: 4.411
Authors: Vlad Serafim; Ajit Shah; Maria Puiu; Nicoleta Andreescu; Dorina Coricovac; Alexander Nosyrev; Demetrios A Spandidos; Aristides M Tsatsakis; Cristina Dehelean; Iulia Pinzaru Journal: Int J Mol Med Date: 2017-07-27 Impact factor: 4.101